Biocon Ltd. Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Consolidated - Balance Sheet Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

EQUITY AND LIABILITIES

No of Months

Share Capital

702.70

521.90

600.30

600.00

Share Warrants & Outstandings

Total Reserve

33,329.10

21,122.10

19,183.40

17,266.60

7,832.20

7,026.90

Shareholder's Funds

34,031.80

21,644.00

19,783.70

17,866.90

8,432.50

7,626.90

Minority Interest

2,589.70

6,068.50

5,491.10

4,621.90

1,037.50

880.70

Long-Term Borrowings

11,258.40

14,300.80

13,580.40

15,290.50

4,008.00

3,764.40

Secured Loans

10,988.40

12,397.90

11,915.70

13,692.30

2,583.80

2,295.20

Unsecured Loans

270.00

1,902.90

1,664.70

1,598.20

1,424.20

1,469.20

Deferred Tax Assets / Liabilities

-313.90

100.00

74.20

80.80

-241.00

-275.40

Other Long Term Liabilities

1641.6

3727.1

1875.6

5144.5

2953.5

2704.5

Long Term Trade Payables

0.00

Long Term Provisions

330.30

260.80

237.60

226.50

91.70

106.20

Total Non-Current Liabilities

12,404.30

16,493.30

15,119.80

20,742.30

6,802.70

5,496.90

Current Liabilities

Trade Payables

6,772.10

6,548.70

6,272.00

3,842.00

1,608.50

1,513.90

Other Current Liabilities

2,963.20

2,243.40

6,110.10

2,039.90

1,183.50

1,189.80

Short Term Borrowings

4,078.40

5,350.10

2,797.20

2,480.20

905.50

1,397.00

Short Term Provisions

255.50

191.60

179.50

148.60

130.50

109.40

Total Current Liabilities

14,069.20

14,333.80

15,358.80

8,510.70

3,828.00

4,210.10

Total Liabilities

63,095.00

58,539.60

55,753.40

51,741.80

20,100.70

18,214.60

ASSETS

Non-Current Assets

0.00

Gross Block

47,342.60

40,108.30

37,284.20

35,020.30

10,928.00

10,044.80

Less: Accumulated Depreciation

11,434.70

8,749.20

7,215.10

5,810.80

4,626.30

3,834.20

Less : Impairment of Assets

0.00

Net Block

35,907.90

31,359.10

30,069.10

29,209.50

6,301.70

6,210.60

Lease Adjustment

0.00

Capital Work in Progress

4,612.70

4,101.70

3,985.20

2,587.50

3,420.30

2,253.50

Intangible assets under development

2,374.00

4,406.70

4,008.10

4,729.50

690.10

546.70

Pre-operative Expenses pending

0.00

Assets in transit

0.00

Non Current Investments

1,089.30

679.70

684.10

742.30

370.20

743.20

Long Term Loans & Advances

989.00

883.60

901.50

1,593.70

492.40

459.50

Other Non Current Assets

364.30

218.40

351.70

287.10

176.40

247.40

Total Non-Current Assets

45,915.20

42,253.40

40,574.20

39,407.80

11,718.40

10,614.20

Current Assets Loans & Advances

Current Investments

689.80

447.30

315.60

1,326.50

1,217.70

1,208.70

Inventories

6,085.70

4,931.10

4,943.90

4,243.70

2,298.20

1,866.60

Sundry Debtors

5,986.80

5,487.90

6,230.60

3,573.20

2,058.20

1,503.30

Cash and Bank

3,193.60

4,120.20

2,258.70

2,400.10

1,747.50

2,015.40

Other Current Assets

419.20

382.70

334.40

277.70

598.30

719.50

Short Term Loans and Advances

804.70

917.00

1,096.00

512.80

462.40

286.90

Total Current Assets

17,179.80

16,286.20

15,179.20

12,334.00

8,382.30

7,600.40

Net Current Assets (Including Current Investments)

3,110.60

1,952.40

-179.60

3,823.30

4,554.30

3,390.30

Total Current Assets Excluding Current Investments

16,490.00

15,838.90

14,863.60

11,007.50

7,164.60

6,391.70

Miscellaneous Expenses not written off

0.00

Total Assets

63,095.00

58,539.60

55,753.40

51,741.80

20,100.70

18,214.60

Contingent Liabilities

1,862.20

2,357.20

1,140.60

947.80

844.40

700.00

Total Debt

14,312.60

15,860.10

15,081.60

17,770.70

4,894.50

3,555.80

Book Value per share (adjusted)

210.6

180.92

164.77

148.81

70.23

63.55

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2026 is -16.51% vs 12.88% in Mar 2025

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -55.96% vs 98.72% in Mar 2025

Fixed Assets

YoY Growth in year ended Mar 2026 is 14.27% vs 4.13% in Mar 2025

Investments

YoY Growth in year ended Mar 2026 is 60.26% vs -0.64% in Mar 2025

Current Assets

YoY Growth in year ended Mar 2026 is 5.49% vs 7.29% in Mar 2025

Compare Balance Sheet Results of Biocon

Select Peers

Figures in Cr

Consolidated - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

702.70

58.08

644.62

1,109.88%

Share Warrants & Outstandings

Total Reserve

33,329.10

32,595.24

733.86

2.25%

Shareholder's Funds

34,031.80

32,653.32

1,378.48

4.22%

Minority Interest

2,589.70

-6.39

2,596.09

40,627.39%

Long-Term Borrowings

11,258.40

1,561.65

9,696.75

620.93%

Secured Loans

10,988.40

1,159.38

9,829.02

847.78%

Unsecured Loans

270.00

402.27

-132.27

-32.88%

Deferred Tax Assets / Liabilities

-313.90

-989.69

675.79

68.28%

Other Long Term Liabilities

1,641.60

307.85

1,333.75

433.25%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

330.30

282.93

47.37

16.74%

Total Non-Current Liabilities

12,404.30

1,162.74

11,241.56

966.82%

Current Liabilities

Trade Payables

6,772.10

4,188.85

2,583.25

61.67%

Other Current Liabilities

2,963.20

3,837.90

-874.70

-22.79%

Short Term Borrowings

4,078.40

6,380.03

-2,301.63

-36.08%

Short Term Provisions

255.50

275.56

-20.06

-7.28%

Total Current Liabilities

14,069.20

14,682.34

-613.14

-4.18%

Total Liabilities

63,095.00

48,492.01

14,602.99

30.11%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

47,342.60

23,954.19

23,388.41

97.64%

Less: Accumulated Depreciation

11,434.70

9,454.41

1,980.29

20.95%

Less : Impairment of Assets

0.00

0.00%

Net Block

35,907.90

14,499.78

21,408.12

147.64%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

4,612.70

3,266.00

1,346.70

41.23%

Intangible assets under development

2,374.00

1,633.96

740.04

45.29%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

1,089.30

251.70

837.60

332.78%

Long Term Loans & Advances

989.00

865.10

123.90

14.32%

Other Non Current Assets

364.30

518.60

-154.30

-29.75%

Total Non-Current Assets

45,915.20

21,329.55

24,585.65

115.27%

Current Assets Loans & Advances

Current Investments

689.80

0.01

689.79

6,897,900.00%

Inventories

6,085.70

10,543.72

-4,458.02

-42.28%

Sundry Debtors

5,986.80

5,745.93

240.87

4.19%

Cash and Bank

3,193.60

8,235.49

-5,041.89

-61.22%

Other Current Assets

419.20

540.70

-121.50

-22.47%

Short Term Loans and Advances

804.70

2,096.61

-1,291.91

-61.62%

Total Current Assets

17,179.80

27,162.46

-9,982.66

-36.75%

Net Current Assets (Including Current Investments)

3,110.60

12,480.12

-9,369.52

-75.08%

Total Current Assets Excluding Current Investments

16,490.00

27,162.45

-10,672.45

-39.29%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

63,095.00

48,492.01

14,602.99

30.11%

Contingent Liabilities

1,862.20

368.26

1,493.94

405.68%

Total Debt

14,312.60

7,941.68

6,370.92

80.22%

Book Value per share (adjusted)

210.60

562.21

-351.61

-62.54%

Annual - Borrowings

Borrowings 14,824.70 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -16.51% vs 12.88% in Mar 2025

Annual - Other Long Term Liabilities

Other Long Term Liabilities 1,641.60 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -55.96% vs 98.72% in Mar 2025

Annual - Fixed Assets

Fixed Assets 40,520.60 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 14.27% vs 4.13% in Mar 2025

Annual - Investments

Investments 1,089.30 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 60.26% vs -0.64% in Mar 2025

Annual - Current Assets

Current Assets 17,179.80 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 5.49% vs 7.29% in Mar 2025